Antibody, Protein & RNA Drugmakers

Own developers of complex biological medicines rather than a general pharmaceutical or research-tools basket. Antibodies, therapeutic proteins and RNA medicines offer distinct routes to treating disease, with specialized development and manufacturing requirements that can reinforce competitive barriers. In an uneven market, the basket pairs established commercial franchises with RNA-platform optionality rather than relying on a single clinical catalyst. Launch basket (equal weight): ABBV, AMGN, LLY, MRK, MRNA, REGN, NVO, ALNY, BMRN Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.